Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Powered By

Top 10 search results for "" in Treatments. To see all results and access other features, sign up for free.

Adcetris (Brentuximab Vedotin)

Overview
Adcetris is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat several types of lymphoma, including classical Hodgkin lymphoma (cHL), systemic anaplastic large cell lymphoma…

read more

Aliqopa (Copanlisib)

Overview
Aliqopa was a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed follicular lymphoma. Aliqopa was withdrawn from the market in November 2023. Aliqopa was indicated in… read more

Adriamycin (Doxorubicin)

The Adriamyxin brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.

Overview

Adriamycin, also known by its drug name doxorubicin, is a prescription medication approved by…

read more

Allogeneic (donor) stem cell transplant

Overview
Stem cell transplant after high-dose chemotherapy is sometimes used to treat people with lymphoma. The purpose of a stem cell transplant in lymphoma is to compensate for higher doses of chemotherapy that will… read more

Arranon (Nelarabine)

Overview
Arranon is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia. Arranon is indicated in cases where… read more

Autologous (self) stem cell transplant

Overview
Stem cell transplant after high-dose chemotherapy is sometimes used to treat people with lymphoma. The purpose of a stem cell transplant in lymphoma is to compensate for higher doses of chemotherapy that will… read more

Arzerra (Ofatumumab)

The Arzerra brand name has been discontinued in the U.S. Generic alternatives may be available.

Overview
Arzerra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic

read more

Beleodaq (Belinostat)

Overview
Beleodaq is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat peripheral T-cell lymphoma that has relapsed or failed to respond to other drugs. Beleodaq is also referred… read more

BiCNU (Carmustine)

Overview
BiCNU, also known by its drug name, carmustine, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.… read more

Blenoxane (Bleomycin)

The Blenoxane brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.

Overview

Blenoxane is a prescription medication approved by the U.S. Food and Drug Administration (FDA)…

read more